News and Comments

Like Dendreon (DNDN) Human Genome might have Bottomed

  Monday, January 09, 2012

As expected, Human Genome Sciences (HGSI) will report on progress with the commercialization of Benlysta® (belimumab) during a presentation at the 30th Annual JPMorgan Healthcare Conference in San Francisco. The drug is approved for the treatment of adult patients with active autoantibody-positive systemic lupus erythematosus (SLE) who are receiving standard therapy. More...

VERTEX (VRTX): At the Finish Line

  Monday, August 09, 2010

When an investigational drug proves it can eradicate a virus we call it a breakthrough. The nearest to approval of the expected breakthroughs is Vertex’ (VRTX) drug telaprevir, a specific hepatitis C virus protease inhibitor. The drug was a blessing for the infected victims who had it in clinical trials. It brought a miracle happy ending to what seemed to be an endless nightmare of acute liver inflammation, chronic liver inflammation, liver cirrhosis, liver transplant and possible liver cancer. We expected telaprevir to be greeted by the government and insurance companies, which spend ton of money on the HCV liver problems where treatments that do not work are, nevertheless, paid for.  More...

Recent Postings



Mirati Therapeutics (MRTX) Incyte (INCY) Onyx (ONXX) Agenus (AGEN) Dendreon (DNDN) ARGOS (ARGS) Zerenex ACADIA (ACAD) Roche (ROCHE) Spike Therapeutics (ONCE) Exelixis (EXEL) Agenus (AGEN Vitae Pharmaceuticals (VTAE) Biocryst (BCRX) Ocular Therapeutix (OCUL) Endometrial Cancer BIOMARIN (BMRN) ISIS (ISIS) Velcade (bortezomib) GUARDIAN HEALTH SERES THERAPEUTICS (MCRB) Human Longevity (HLI) Sangamo (SGMO) Theravance (THRX) ARCA (ABIO) Alder Biopharmaceuticals (ALDR) Illumina (ILMN) Vertex (VRTX) REGULUS (RGLS) CEMPRA (CEMP) Galena (GALE) Sanofi-Aventis (SAN) AstraZeneca (AZN) Intercept (ICPT) galapagos (GLPG) Abbott Laboratories (ABT) Idenix (IDIX) KERYX (KERX) Benlysta (belimumab) HALOZYME (HALO) Trastuzumab-DM1 PORTOLA (PTLA) Herceptin SUNESIS PHARMACEUTICALS (SNSS) Anacor (ANAC) SYNTA (SNTA) Sanofi (SNY) INNOVIVA (INVA) TOKAI (TKAOI) Intermune (ITMN) VANDA (VNDA) Adaptimmune (ADAP) Bristol-Myers Squibb (BMY) Ionis (IONS) CRISPR Therapeutics (CRSP) Sarepta (SRPT) Advaxis (ADXS) Global Cell Therapeutics (GBT) ImmunoGen (IMGN) PTC Therapeutics (PTCT) OSI (OSIP) RenenxBio (RGNX) Anadys (ANDS) NEKTAR (NKTR)) Aimmune Therapeutics (AIMT) Xoma (XOMA) Intrexon (XON) C4 Therapeutics Sanofi (SNA) MODERNA Prolor Biotech (PBTH) Cytokinetics (CYTK) Roche (RHHBY) IDERA (IDRA) Merck (MRK) KITE (KITE) CompuGen (CGEN) Amgen (AMGN) Ridaforolimus Rapamune Gilead (GILD) Sequenom (SQNM) Bellicum (BLCM) Biogen Idec (BIIB) Elan (ELN) NOVOCURE (NVCR) NANTKWEST (NK) Prosensa (RNA) Alnylam (ALNY) Telaprevir Micromet (MITI) Tysabri Genentech Human Genome Sciences (HGSI) Ariad (ARIA) Multiple Myeloma Inovio (INO) AERIE PHARMACEUTICALS Theravance Bio Pharma (TBPH) AGOS (ARGS) Valeant Pharmaceuticals International (VRX) Dynavax (DVAX) Array Pharmaceuticals (ARRY) ABBVIE (ABBV) JUNO (JUNO) Jazz Pharmaceuticals (JAZZ) Seattle Genetics (SGEN) Regeneron (REGN) ZALTRAP™ GlaxoSmithKline (GSK) Pluristem (PSTI) Ziofpharm (ZIOP) ADVENTRIX (ANX) Auspex (ASPX) Editas (EDIT) Revlimid (lenolidamide)